New pricing and payment models for cost-effective and affordable health innovations
Summary
The Cluster Health is under Pillar 2 of Horizon Europe. Its role is to advance knowledge and capabilities, improve understanding of health and diseases, develop innovative methodological and technological solutions to better manage health and diseases, as well as to design sustainable approaches for the digital transformation and delivery of integrated, person-centred and equitable health and care services.
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Call
Detailed Call Description
Applicants should propose activities in all of the following areas:
- Affordability of health innovations.
- Variety of pricing/payment schemes in the EU.
- Cost-effectiveness and budget impact (including life-time indirect medical costs).
- Impact of payment schemes (e.g. pay-for-performance/multi-annual instalments) on long-term competition in health technology markets, in particular the pharmaceutical market.
- Potential influence of post-launch evidence-generation plans agreed with regulators and downstream decision makers (HTAs, payers) on the payment models.
- Transparent and comprehensive assessment of technology and medicine development costs, taking into account public investments and incremental character of some innovations (e.g. new indications).
- Development, integration and harmonisation of tools that allow for validation and revision of clinical evidence and cost-effectiveness, and long-term financial planning for effective and transparent decision-making.
- New methods for definition of cost-effectiveness thresholds, integration of greener production and environmental impact, rational applications in real world contexts, comparative analysis of influence in decision-making and influence in the formulation of prices of technologies.
- Potential equity issues derived by payment models and the measures for their mitigation.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
Contribution per project: €5,00 million
Eligibility For Participation Notes
- Health authorities and insurers
- Health industries
- Patients and health care providers
- Health authorities, insurers and health care providers
Programme Category
EU Competitive ProgrammesTotal Budget
€15,00 millionThematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Central Government
- Large Enterprises
- Private Bodies
- Researchers/Research Centers/Institutions
- State-owned Enterprises
Call Opening Date
06/10/2021Call Closing Date
21/04/2022National Contact Point(s)
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.O.Box 23422, 1683 Nicosia
Telephone: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/
Mr Marinos Fotiadis
Contact Phone: 22 205 048
E-mail: mphotiades@research.org.cy
Website: https://www.research.org.cy/
Dr Ioannis Theodorou
Contact Phone: 22 205 038
E-mail: itheodorou@research.org.cy
Website: https://www.research.org.cy/
(Publish Date: 26/11/2021-for internal use only)
EU Contact Point
European Commission, Directorate-General for Research and Innovation
https://ec.europa.eu/info/departments/research-and-innovation_en#contact